Inception Sciences

company

About

Inception Sciences creates therapies with transformative potential to address diseases and disorders with significant unmet need.

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
$10M
Industries
Biotechnology,Health Care,Pharmaceutical,Therapeutics
Founded date
Jan 1, 2011
Number Of Employee
11 - 50
Operating Status
Active

Founded in 2011, Inception Sciences is a small molecule pharmaceutical incubator. Their focus is on creating high-value therapies with transformative potential to address diseases and disorders with significant unmet needs. Through partnerships with academic experts, they are translating biological insights into highly-targeted, novel drugs. Their team has a proven track record of drug discovery, having played pivotal roles in the discovery of clinical-stage compounds for the treatment of fibrosis, asthma, and COPD at Amira Pharmaceuticals, and of several high-profile drugs at Merck.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$10M
Inception Sciences has raised a total of $10M in funding over 2 rounds. Their latest funding was raised on Dec 9, 2013 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 9, 2013 Series A $10M 1 Versant Ventures Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Inception Sciences is funded by 1 investors. Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Versant Ventures Yes Series A